MedTrace Logo

Pelvic Stabilization Belt Combined With Exercise Therapy on Pelvic Girdle Pain and Mobility in Post-partum Women

NCT07803302 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2026-09-03

No results posted yet for this study

Summary

This randomized controlled trial aims to evaluate the effects of a pelvic stabilization belt combined with exercise therapy on pelvic girdle pain and mobility in postpartum women. The study will compare combined pelvic stabilization belt and exercise therapy with exercise therapy alone. Pain, functional mobility, and pelvic girdle-related disability will be assessed to determine whether adding a pelvic stabilization belt provides additional benefits for postpartum women experiencing pelvic girdle pain.

Conditions

  • Pelvic Girdle Pain

Interventions

DEVICE

Pelvic Stabilization Belt

Participants assigned to the experimental group will use a pelvic stabilization belt in addition to standard pelvic floor physical therapy for 4 weeks. The belt will be positioned around the pelvic ring at the level of the greater trochanters to provide pelvic compression and support pelvic stability. Participants will be instructed to wear the belt for at least 4 hours per day during functional activities, including walking, standing, household work, and childcare activities.

BEHAVIORAL

Standard Pelvic Floor Physical Therapy

Participants in both groups will receive standard pelvic floor physical therapy for 4 weeks. Treatment will include patient education regarding spinal stability, lumbopelvic alignment, posture, ergonomic strategies for breastfeeding, lifting and infant care, gait training, and psychological support. Pelvic floor muscle training will include Kegel exercises performed in supine or seated positions, with 5-10-second contractions, 10-15 repetitions per set, and 3-4 sets per day, emphasizing isolated pelvic floor muscle activation without compensatory abdominal or gluteal contraction.

Sponsors & Collaborators

  • University of Lahore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-22
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07803302 on ClinicalTrials.gov